Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13–April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, zoonoses, SARS-CoV-2, Mortality, Hospitalization, Pneumonia, respiratory diseases, ICU, outcomes, United States, California, coronavirus diseases, 【초록키워드】 Hospitalized, intensive care, hospital, cardiovascular disease, outcome, Region, Patient, USA, patients, COVID-19 patients, pulmonary disease, hospitalized COVID-19 patient, death rate, San Francisco Bay, Volume, reported, the United State, median, conditions, Limited, patients hospitalized, with COVID-19, 【제목키워드】 USA,